With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. In a world of Ozempic, Wegovy, and Zepbound, one ...

Week 9 of the UFL season got off to a fast start on Friday night, as the Orlando Storm won their third straight game, defeating the DC Defenders, 27-19. The excitement continued as the Columbus ...